Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

The role of the T3 molecular-complex on human lymphocyte-T mediated cyto-toxicity

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Tsoukas, C. D.
  • Valentine, M.
  • Lotz, Martin
  • Vaughan, J. H.
  • Carson, D. A.

publication date

  • 1985

journal

  • Advances in Experimental Medicine and Biology  Journal

abstract

  • The above overview of the experimental data clearly indicates that the T3 molecular complex is intimately involved in T cell activation. The precise role of the T3 complex in the activation process, however, is not clearly understood. The surface association of the T3 complex with the antigen receptor, along with the ability of antibodies to these molecules to render T cells receptive to IL2, reveal a possible mechanism by which specific antigen initiates T cell activation and growth. However, it would be difficult to reconcile this specific effect of anti-T3 antibodies with their effect on CTL function. Since the T3 complex is not a specific marker of any particular effector T cell population, but it is found on all T lymphocytes, we favor the hypothesis that the complex is involved in a more fundamental step of T cell activation, and we believe that triggering of the 'lethal hit', expression of IL2 receptors, and secretion of IL2 are mere manifestations of this basic process. The natural ligand of the antigen receptor is obviously the specific antigen. However, the natural ligand of the T3 complex is unknown. Possibly, its natural ligand is the antigen receptor itself after it has interacted with antigen. A simple scenario, then of the early events of T cell activation would include antigen recognition and binding, followed by an interaction between the antigen receptor and the T3 complex which then activates or allows expression of specific pathways depending on the particular effector population involved. Thus, the inhibition of CTL function by anti-T3 antibodies could be explained by interference with the antigen receptor-T3 complex interaction following target cell recognition. This interaction may be the event that signals the initiation of the 'lethal hit' process.

subject areas

  • Antibodies, Monoclonal
  • Antigens, CD3
  • Antigens, Surface
  • Binding, Competitive
  • Concanavalin A
  • Cytotoxicity, Immunologic
  • Humans
  • In Vitro Techniques
  • Lymphocyte Activation
  • Lymphokines
  • Monocytes
  • T-Lymphocytes, Cytotoxic
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0065-2598

PubMed ID

  • 2931002
scroll to property group menus

Additional Document Info

start page

  • 365

end page

  • 385

volume

  • 184

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support